UnknownNot Applicable

Role of Prophylactic Biliary Stent in Reducing the Recurrence of Choledocholithiasis

480 participantsStarted 2023-09-30

Plain-language summary

We planned this multicenter randomized controlled trial to study the role of a prophylactic biliary stent in recurrence of stones and biliary complications in patients awaiting cholecystectomy after biliary stone clearance

Who can participate

Age range18 Years – 80 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Age between 18-80 years * Cases of cholelithiasis with concomitant CDL in whom CBD clearance is achieved will be included. Exclusion Criteria: * Informed consent not available * Patients opting for single stage surgery * Previous hepatobiliary surgery * Failure to completely clear CDL on ERC * Concomitant benign biliary strictures (like chronic pancreatitis, portal cavernoma cholangiopathy, post cholecystectomy, primary biliary cholangitis related) * Previous cholecystectomy patients * Associated malignancy * Coagulopathy(INR\>1.5, platlets\<1lac) * Severe cholangitis

What they're measuring

To compare the CDL recurrence rate between the 2 groups

Timeframe: 3 Months

Trial details

NCT IDNCT06060002

SponsorAsian Institute of Gastroenterology, India

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2025-12-30

View on ClinicalTrials.gov More Choledocholithiasis trials